|
Salivary Glands
|
D012469 |
[Glands that secrete SALIVA in the MOUTH. There are three pairs of salivary glands (PAROTID GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND).
] |
|
Campylobacter coli
|
B03.660.150.235.250.500.100 |
|
|
Campylobacter
|
B03.660.150.235.250.500 |
|
|
Ferrichrome
|
D02.092.570.394.380 |
|
|
Hydroxamic Acids
|
D02.092.570.394 |
|
|
Sulfasalazine
|
D012460 |
[A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
] |
|
Socialization
|
I01.880.853.934 |
|
|
Saline Solution, Hypertonic
|
D012462 |
[Hypertonic sodium chloride solution. A solution having an osmotic pressure greater than that of physiologic salt solution (0.9 g NaCl in 100 ml purified water).
] |
|
Water Cycle
|
G01.311.977 |
|
|
Saliva
|
D012463 |
[The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin.
] |
|
Saliva, Artificial
|
D012464 |
[A solution used for irrigating the mouth in xerostomia and as a substitute for saliva.
] |
|
Medial Tibial Stress Syndrome
|
C10.668.491.087 |
|
|
Salivary Duct Calculi
|
D012465 |
[Presence of small calculi in the terminal salivary ducts (salivary sand), or stones (larger calculi) found in the larger ducts.
] |
|
Coinfection
|
C01.218 |
|
|
Infections
|
C01 |
|
|
Salivary Gland Diseases
|
D012466 |
[Diseases involving the SALIVARY GLANDS.
] |
|
Pharmaceutical Research
|
H01.770.644.145.442 |
|
|
Mesothelioma, Malignant
|
C04.588.894.797.640.350 |
|
|
Spectinomycin
|
D09.408.051.836 |
|
|
Salmonella Infections
|
D012480 |
[Infections with bacteria of the genus SALMONELLA.
] |
